TWD 74.5
(-1.97%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -5 Million | -66.52 Million | 952 Thousand | -25.4 Million | -210.14 Million |
Net Income | -10.5 Million | -129.02 Million | -28.26 Million | -71.17 Million | -315.95 Million |
Depreciation & Amortization | 20.87 Million | 38.64 Million | 55.98 Million | 70.06 Million | 56.67 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 1.58 Million | 4.89 Million | -29.6 Million | -24.12 Million | 42.49 Million |
Other non-cash items | 7.81 Million | 10.94 Million | 13.5 Million | 12.44 Million | 6.64 Million |
Investing Cash Flow | 17.24 Million | -6.77 Million | -13.71 Million | -43.79 Million | -67.14 Million |
Investments in PPE | -949 Thousand | -4.18 Million | -13.29 Million | -5.12 Million | -52.66 Million |
Acquisitions | 607 Thousand | - | -2.6 Million | 250 Thousand | - |
Investment purchases | -53 Thousand | -64.74 Million | 756 Thousand | -43.49 Million | - |
Sales/Maturities of investments | 17.72 Million | 62.14 Million | - | - | - |
Other Investing Activities | -84 Thousand | -4.37 Million | 1.3 Million | 1.57 Million | 176 Thousand |
Financing Cash Flow | -12.79 Million | 17.97 Million | -15.64 Million | 142.17 Million | 288.17 Million |
Debt repayment | -3.36 Million | -827 Thousand | -15.64 Million | -142.17 Million | -178 Thousand |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | 20 Million | - | - | - |
Other Financing Activities | -3.14 Million | 4.77 Million | - | 170 Million | 30 Million |
Accounts receivables | -488 Thousand | 2.69 Million | -6.36 Million | -25.76 Million | 17.8 Million |
Accounts payables | 243 Thousand | - | - | - | - |
Inventory | 1.57 Million | 2.51 Million | 9.31 Million | 556 Thousand | 5.46 Million |
Other working capital | 173 Thousand | -472 Thousand | -19.39 Million | -26.87 Million | 19.22 Million |
Cash at beginning of period | 63.81 Million | 118.71 Million | 147.28 Million | 74.61 Million | 56.08 Million |
Cash at end of period | 50.12 Million | 63.81 Million | 118.71 Million | 147.28 Million | 74.61 Million |
Capital Expenditure | -949 Thousand | -4.18 Million | -13.29 Million | -5.12 Million | -52.66 Million |
Effect of forex changes on cash | -13.13 Million | 417 Thousand | -154 Thousand | -304 Thousand | 7.64 Million |
Net cash flow / Change in cash | -13.68 Million | -54.9 Million | -28.56 Million | 72.67 Million | 18.53 Million |
Free Cash Flow | -5.95 Million | -70.7 Million | -12.33 Million | -30.52 Million | -262.81 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -10.43 Million | 13.1 Million | -3.55 Million | -10.5 Million | 2.23 Million | -7.9 Million |
Depreciation & Amortization | 2.29 Million | 2.38 Million | 3.33 Million | 20.87 Million | 4.89 Million | 5.62 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 5.33 Million | -9.86 Million | 5.22 Million | 1.58 Million | -3.1 Million | 10.01 Million |
Other non-cash items | 1.9 Million | 2.03 Million | 1.94 Million | 7.81 Million | 2.05 Million | 1.92 Million |
Investing Cash Flow | -2.16 Million | 7.33 Million | 7.55 Million | 17.24 Million | -71 Thousand | 8.52 Million |
Investments in PPE | -504 Thousand | -158 Thousand | -128 Thousand | -949 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -1.77 Million | - | - | -53 Thousand | - | -1000.00 |
Sales/Maturities of investments | - | 1.94 Million | 7.68 Million | 17.72 Million | -71 Thousand | 8.51 Million |
Other Investing Activities | 117 Thousand | 5.54 Million | 7.68 Million | -84 Thousand | -71 Thousand | 8.52 Million |
Financing Cash Flow | -2.39 Million | -4.05 Million | -3.74 Million | -12.79 Million | -3.47 Million | -2.41 Million |
Debt repayment | -867 Thousand | -859 Thousand | -851 Thousand | -3.36 Million | -842 Thousand | -837 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.52 Million | -1.63 Million | -1.34 Million | -3.14 Million | -1.04 Million | - |
Accounts receivables | -436 Thousand | 511 Thousand | -488 Thousand | -488 Thousand | -656 Thousand | 6 Million |
Accounts payables | 632 Thousand | - | - | - | - | - |
Inventory | 419 Thousand | 110 Thousand | 646 Thousand | 1.57 Million | -181 Thousand | 693 Thousand |
Other working capital | 4.47 Million | -381 Thousand | 2.9 Million | 173 Thousand | -613 Thousand | 3.3 Million |
Cash at beginning of period | 52.19 Million | 49.58 Million | 50.53 Million | 63.81 Million | 50.7 Million | 40.75 Million |
Cash at end of period | 51.48 Million | 52.19 Million | 50.12 Million | 50.12 Million | 50.53 Million | 50.7 Million |
Capital Expenditure | -504 Thousand | -158 Thousand | -128 Thousand | -949 Thousand | - | - |
Effect of forex changes on cash | 1.17 Million | -274 Thousand | -406 Thousand | -13.13 Million | 69 Thousand | -20 Thousand |
Net cash flow / Change in cash | -707 Thousand | 2.6 Million | -403 Thousand | -13.68 Million | -171 Thousand | 9.95 Million |
Free Cash Flow | 2.16 Million | -554 Thousand | -3.93 Million | -5.95 Million | 3.3 Million | 3.86 Million |
MLSUM
BIO
TGP
KHAZANCHI
VSSAB-B
4055